Earlier quoted context omitted.
That sounds pretty inexpensive. It looks like the previous standard of care cost $10-15,000 and wasn't generally curative. Meanwhile, the long-term cost of a progressing hep-c infection is quite high.
In the context of a decietful medical system that bills pie in the sky amounts for rendering basic care, a $100k cure for Hepatitis C might seem reasonable. But those who need it most are dying due to this pricing scam, which is standard for our healthcare in the US.
Those who need it most are dying not due to the "pricing scam", but because they're incarcerated and therefore prohibited from receiving curative HCV treatment, at any price.
The sticker price is high, but it's meaningless, because almost nobody is going to be paying the sticker price.
Also, if you want to make a statement about healthcare pricing in the US, Sovaldi is literally the worst example you could pick. For the first few years after it was available outside the US, Sovaldi was significantly cheaper in the US than in it was elsewhere.